Know Cancer

or
forgot password

Hospital-based Epidemiological Study on the Distribution of Human Papillomavirus (HPV) Types in Adult Women Diagnosed With Invasive Cervical Cancer (ICC) in New Zealand


N/A
18 Years
N/A
Not Enrolling
Female
Cervical Cancer

Thank you

Trial Information

Hospital-based Epidemiological Study on the Distribution of Human Papillomavirus (HPV) Types in Adult Women Diagnosed With Invasive Cervical Cancer (ICC) in New Zealand


Inclusion Criteria:



- A female aged 18 years and above at the time of cervical specimen collection, and
currently residing in New Zealand.

- Histological diagnoses of invasive cervical cancer stage IB or greater, within at
least the last 3 years.

- Written informed consent obtained from the subject/ next of kin/ Legally acceptable
representative.

- Availability of cervical specimen on which the diagnosis was made prior to any
chemotherapy or radiotherapy.

- The cervical specimen should be of appropriate size and with regular tissue
specimens.

- The cervical specimen should be adequately preserved.

- All links to the subject's identity should be removed from the paraffin block.

Exclusion Criteria:

Not Applicable.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Outcome Measure:

Occurrence of HPV-16 and HPV-18 in women with invasive cervical cancer

Outcome Time Frame:

At least the last 3 years from the time of study start

Safety Issue:

No

Principal Investigator

GSK Clinical Trials

Investigator Role:

Study Director

Investigator Affiliation:

GlaxoSmithKline

Authority:

New Zealand: Medsafe

Study ID:

111050

NCT ID:

NCT01328028

Start Date:

April 2009

Completion Date:

April 2011

Related Keywords:

  • Cervical Cancer
  • Invasive cervical cancer
  • Human papillomavirus
  • Uterine Cervical Neoplasms

Name

Location